Variation in use and dosing escalation of renin angiotensin system, mineralocorticoid receptor antagonist, angiotensin receptor neprilysin inhibitor and beta-blocker therapies in heart failure and reduced ejection fraction: Association of comorbidities
Author:
Funder
Novartis Pharmaceuticals Corporation
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference43 articles.
1. Assessment of limitations to optimization of guideline-directed medical therapy in heart failure from the GUIDE-IT Trial: A secondary analysis of a randomized clinical trial;Fiuzat;JAMA Cardiol,2020
2. Titration of medical therapy for heart failure with reduced ejection fraction;Greene;J Am Coll Cardiol,2019
3. The real-world evidence of heart failure: findings from 41 413 patients of the ARNO database;Maggioni;Eur J Heart Fail,2016
4. Effects of combined renin-angiotensin-aldosterone system inhibitor and beta-blocker treatment on outcomes in heart failure with reduced ejection fraction: insights from BIOSTAT-CHF and ASIAN-HF registries;Ouwerkerk;Eur J Heart Fail,2020
5. Real world heart failure epidemiology and outcome: A population-based analysis of 88,195 patients;Farré;PLoS One,2017
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Use of heart failure medical therapy before and after a cancer diagnosis: A longitudinal study;ESC Heart Failure;2024-07-23
2. Association Between Cardiovascular Disease and Chronic Kidney Disease Prevalence and Characteristics in Saudi Arabia;Cureus;2023-12-08
3. Non‐cardiac comorbidities and intensive up‐titration of oral treatment in patients recently hospitalized for heart failure: Insights from the STRONG‐HF trial;European Journal of Heart Failure;2023-10-04
4. Guideline-Directed Medical Therapy Tolerability in Patients With Heart Failure and Mitral Regurgitation;JACC: Heart Failure;2023-07
5. Prevalence and Prognostic Implication of Atrial Fibrillation in Heart Failure Subtypes: Systematic Review and Meta-Analysis;Heart, Lung and Circulation;2023-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3